PURPOSE: To find a biomarker for gastric adenocarcinomas (GA). METHODS: Ten protein expression profiles of GA and paired non-neoplastic mucosa tissues were analyzed by two-dimensional gel electrophoresis. Forty-two protein spots that were differentially expressed by twofold or greater between cancer and normal mucosa tissue were excised and identified by MALDI-TOF/TOF MS. One of the over-expressed proteins identified in GA was transgelin, which was chosen for further verification by immunohistochemistry and western blotting. RESULTS: Forty-two distinct proteins that were differentially expressed at least twofold between the tissues were identified. Expression of 29 of these proteins was decreased (ratio >or= 2, P < 0.01), including adenosine deaminase; and 13 proteins displayed over-expression in cancer tissue (ratio >or= 2, P < 0.01), including transgelin. The results of immunohistochemistry confirmed that transgelin was indeed over-expressed in 22 cases of GA (22/41, 53.66%), with strong cytoplasmic staining in cancer cells of positive samples, this was absent in most paired non-neoplastic mucosa cells or gastric ulcer tissues (n = 20). Transgelin was found over-expressed in 21 samples of cancer tissue (21/41, 51.22%) when detected by western blot. CONCLUSION: This work demonstrates that differentially expressed proteins can be identified by proteomics technology combined with immunohistochemistry and western blot analyses. We have identified one such protein, transgelin, as a novel biomarker for GA.
PURPOSE: To find a biomarker for gastric adenocarcinomas (GA). METHODS: Ten protein expression profiles of GA and paired non-neoplastic mucosa tissues were analyzed by two-dimensional gel electrophoresis. Forty-two protein spots that were differentially expressed by twofold or greater between cancer and normal mucosa tissue were excised and identified by MALDI-TOF/TOF MS. One of the over-expressed proteins identified in GA was transgelin, which was chosen for further verification by immunohistochemistry and western blotting. RESULTS: Forty-two distinct proteins that were differentially expressed at least twofold between the tissues were identified. Expression of 29 of these proteins was decreased (ratio >or= 2, P < 0.01), including adenosine deaminase; and 13 proteins displayed over-expression in cancer tissue (ratio >or= 2, P < 0.01), including transgelin. The results of immunohistochemistry confirmed that transgelin was indeed over-expressed in 22 cases of GA (22/41, 53.66%), with strong cytoplasmic staining in cancer cells of positive samples, this was absent in most paired non-neoplastic mucosa cells or gastric ulcer tissues (n = 20). Transgelin was found over-expressed in 21 samples of cancer tissue (21/41, 51.22%) when detected by western blot. CONCLUSION: This work demonstrates that differentially expressed proteins can be identified by proteomics technology combined with immunohistochemistry and western blot analyses. We have identified one such protein, transgelin, as a novel biomarker for GA.
Authors: Matthias P A Ebert; Sabine Krüger; Marie-Laure Fogeron; Stephanie Lamer; Jie Chen; Matthias Pross; Hans-Ulrich Schulz; Hermann Lage; Steffen Heim; Albert Roessner; Peter Malfertheiner; Christoph Röcken Journal: Proteomics Date: 2005-04 Impact factor: 3.984
Authors: Valerie Dubé; Jörg Grigull; Leroi V DeSouza; Shaun Ghanny; Terence J Colgan; Alexander D Romaschin; K W Michael Siu Journal: J Proteome Res Date: 2007-06-07 Impact factor: 4.466
Authors: Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend Journal: Nature Date: 2002-01-31 Impact factor: 49.962
Authors: Christian Melle; Günther Ernst; Bettina Schimmel; Annett Bleul; Roland Kaufmann; Merten Hommann; Konrad K Richter; Wolfgang Daffner; Utz Settmacher; Uwe Claussen; Ferdinand von Eggeling Journal: J Proteome Res Date: 2005 Sep-Oct Impact factor: 4.466
Authors: Markus Roessler; Wolfgang Rollinger; Stefan Palme; Marie-Luise Hagmann; Peter Berndt; Alfred M Engel; Bernd Schneidinger; Michael Pfeffer; Herbert Andres; Johann Karl; Heinz Bodenmüller; Josef Rüschoff; Thomas Henkel; Gerhard Rohr; Siegbert Rossol; Wolfgang Rösch; Hanno Langen; Werner Zolg; Michael Tacke Journal: Clin Cancer Res Date: 2005-09-15 Impact factor: 12.531
Authors: Peter K Cheung; Bruce Woolcock; Hans Adomat; Margaret Sutcliffe; Terry C Bainbridge; Edward C Jones; Douglas Webber; Thomas Kinahan; Marianne Sadar; Martin E Gleave; Juergen Vielkind Journal: Cancer Res Date: 2004-09-01 Impact factor: 12.701
Authors: Brian L Hood; Jelena Grahovac; Melanie S Flint; Mai Sun; Nuno Charro; Dorothea Becker; Alan Wells; Thomas P Conrads Journal: J Proteome Res Date: 2010-07-02 Impact factor: 4.466
Authors: Yashwanth Subbannayya; Nazia Syed; Mustafa A Barbhuiya; Remya Raja; Arivusudar Marimuthu; Nandini Sahasrabuddhe; Sneha M Pinto; Srikanth Srinivas Manda; Santosh Renuse; H C Manju; Mohammed Abdul Lateef Zameer; Jyoti Sharma; Mariana Brait; Kotteazeth Srikumar; Juan Carlos Roa; M Vijaya Kumar; K V Veerendra Kumar; T S Keshava Prasad; Girija Ramaswamy; Rekha Vijay Kumar; Akhilesh Pandey; Harsha Gowda; Aditi Chatterjee Journal: Cancer Biol Ther Date: 2015 Impact factor: 4.742